Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Vasopeptidase Inhibitors MeSH Descriptor Data 2026


MeSH Heading
Vasopeptidase Inhibitors
Tree Number(s)
D27.505.519.389.745.085.500
Unique ID
D000075563
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000075563
Scope Note
A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II.
Entry Term(s)
ACE-NEP Inhibitors
NEP-ACE Inhibitors
Vasopeptidase Inhibitor
Registry Numbers
0
Previous Indexing
Angiotensin-Converting Enzyme Inhibitors (1999-2017)
Neprilysin/antagonists and inhibitors (1999-2017)
Public MeSH Note
2018
History Note
2018
Date Introduced
2018/01/01
Last Updated
2021/06/30
Vasopeptidase Inhibitors Preferred
page delivered in 0.122s